Loading...
 
 Warning
  • User not in any of the required groups for GroupSelector field

128

Items
Selected Document Category:Published Document
Source:Nanotechnology Characterization Laboratory
Anticipated Publication Year:
Publication Year:2010
Acronym:NCL
Identifier:GTA-6
Document Title:HepG2 Hepatocarcinoma Apoptosis Assay
url:http://ncl.cancer.gov/NCL_Method_GTA-6.pdf
Scope:This protocol describes the monitoring of nanoparticle treated human hepatocarcinoma cells (HepG2) for apoptosis, as part of the in vitro NCL preclinical characterization cascade. The protocol utilizes a fluorescent method to determine the degree of caspase-3 activation.
Keywords:HepG2, caspase-3 activation
Type of Document:e. Specification
Issues Areas:Measurement and Characterizations
Primary Category:Chemicals e.g. pesticides, pharmaceuticals, paints, basic chemicals
Additional Categories
Goal or Need:
Intended Stakeholders:
Is it Being Implemented:
Submitter's Name:Admin
Submitter's e-mail:[email protected]
Submitter's Company:ANSI
Additional Comments:
Contact for Additional Info:http://ncl.cancer.gov/working_assay-cascade_download.asp
Selected Document Category:Published Document
Source:Nanotechnology Characterization Laboratory
Anticipated Publication Year:
Publication Year:2010
Acronym:NCL
Identifier:GTA-6
Document Title:HepG2 Hepatocarcinoma Apoptosis Assay
url:http://ncl.cancer.gov/NCL_Method_GTA-6.pdf
Scope:This protocol describes the monitoring of nanoparticle treated human hepatocarcinoma cells (HepG2) for apoptosis, as part of the in vitro NCL preclinical characterization cascade. The protocol utilizes a fluorescent method to determine the degree of caspase-3 activation.
Keywords:HepG2, caspase-3 activation
Type of Document:e. Specification
Issues Areas:Measurement and Characterizations
Primary Category:Chemicals e.g. pesticides, pharmaceuticals, paints, basic chemicals
Additional Categories
Goal or Need:
Intended Stakeholders:
Is it Being Implemented:
Submitter's Name:Admin
Submitter's e-mail:[email protected]
Submitter's Company:ANSI
Additional Comments:
Contact for Additional Info:http://ncl.cancer.gov/working_assay-cascade_download.asp



::::